Exploring the mechanism of Zhengxintai Formula for the treatment of coronary heart disease based on network pharmacology

Zicheng Lin,Mingshuo Yang,Jiting Wu,Liming Pan
DOI: https://doi.org/10.1097/md.0000000000040065
IF: 1.6
2024-10-15
Medicine
Abstract:Coronary atherosclerotic heart disease (CHD) is defined as heart disease caused by narrowing or obstruction of the lumen of blood vessels due to coronary atherosclerosis and ischemia or necrosis of the myocardium due to functional changes in the coronary arteries. CHD patients do not present with overt clinical symptoms at an early stage, but with prolonged illness symptoms such as chest pain and shortness of breath can occur. And often worsens following activity, which may affect the patient's ability to carry out daily activities and may even lead to adverse outcomes such as myocardial infarction and heart failure. Population growth and aging are leading to a significant increase in epidemiological indicators of CHD among cardiovascular diseases worldwide, becoming one of the most important threats to public health. [ 1 ] China has an existing population of approximately 330 million people with cardiovascular disease, including approximately 11.39 million patients with CHD. The last 30 years have also seen significant changes in the spectrum of cardiovascular disease in China: the burden of rheumatic heart disease in China has been on a declining trend, although atherosclerotic cardiovascular disease has greatly increased and is likely to become the number 1 cause of death in the nation in the near future instead of stroke. [ 2 , 3 ]
medicine, general & internal
What problem does this paper attempt to address?